7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2003-09-30 
      
    		                                             
      operating activities
    		                                             
      net income
    		2,619,000 12,700,000 11,553,000 10,445,000 7,696,000 9,367,000 9,603,000 6,309,000 15,145,000 20,464,000 21,419,000 16,488,000 11,889,000 13,721,000 12,301,000 8,951,000 10,702,000 8,891,000 7,177,000 2,658,000 12,962,000 10,488,000 3,653,000 5,603,000 8,043,000 7,866,000 1,824,000 5,263,000 9,055,000 6,735,000 5,528,000 702,000 6,278,000 4,156,000 1,518,000 5,101,000 4,741,000 2,755,000 2,658,000 3,045,000 206,000 3,680,000 -256,000 2,488,000 -510,000 
      adjustments to reconcile net income to net cash from operations:
    		                                             
      depreciation and amortization
    		5,806,000 5,686,000 5,397,000 4,848,000 5,322,000 5,246,000 5,414,000 5,312,000 4,638,000 4,689,000 4,275,000 6,242,000 3,314,000 3,853,000 3,021,000 5,009,000 3,723,000 3,687,000 3,145,000 3,758,000 3,419,000 3,304,000 3,357,000 3,904,000 3,305,000 3,399,000 3,140,000 3,149,000 2,771,000 3,259,000 3,265,000 3,682,000 3,235,000 2,901,000 2,972,000 3,394,000 3,000,000 2,892,000 2,710,000 2,438,000 2,898,000 2,946,000 3,250,000 3,273,000 1,916,000 
      deferred income taxes
    		2,071,000 -327,000 -479,000 4,096,000 -1,099,000 -1,527,000 -386,000 605,000 -826,000 -481,000 -1,530,000 -1,507,000 1,442,000 -2,028,000 -563,000 5,857,000 -888,000 -3,346,000 4,921,000 -4,444,000 387,000 -486,000 1,163,000 229,000 -791,000 -808,000 96,000 794,000 -18,000 -308,000 -154,000 2,579,000 647,000 -501,000 -289,000 3,393,000 -329,000 -792,000 -23,000 975,000 -810,000 108,000 -1,217,000 -1,330,000 1,482,000 
      share-based compensation expense
    		1,375,000 1,706,000 892,000 1,463,000 632,000 934,000 383,000 858,000 1,299,000 1,725,000 1,066,000 1,187,000 1,496,000 890,000 1,023,000 872,000 1,364,000 893,000 1,034,000 1,043,000 1,458,000 612,000 976,000 1,052,000 1,388,000 1,028,000 928,000 1,935,000 584,000 986,000 731,000 868,000 1,047,000 579,000 561,000 439,000 421,000 143,000 363,000 794,000 -982,000 -53,000 489,000 754,000  
      pension termination expense
    		                                             
      gain on sale of property and equipment
    		42,000 19,000 -37,000 191,000    -21,000 -2,501,000 28,000 16,000  11,000 -50,000 -792,000  -12,000   1,093,000   0 57,000 -47,000 33,000 -33,000   -68,000 -31,000   -6,000 -7,000         -1,000  
      other
    		2,023,000 1,271,000 -228,000 -171,000 532,000 -763,000 1,230,000 -5,783,000 2,122,000 2,154,000 1,942,000 -100,000 -467,000                                 
      changes in operating assets and liabilities
    		 5,873,000 -11,443,000  -3,630,000 15,046,000 -8,648,000      -8,744,000 -17,624,000 -17,420,000                               
      contributions to company pension plan
    		               0    0    0    0                  
      net cash from operating activities
    		18,940,000 26,928,000 5,655,000 24,067,000 9,366,000 28,294,000 5,753,000 19,288,000 42,504,000 20,420,000 25,430,000 17,031,000 15,299,000 -1,002,000 -5,175,000 9,512,000 10,025,000 825,000 13,236,000 8,085,000 24,373,000 12,239,000 -3,055,000 6,548,000 14,834,000 5,334,000 501,000 15,889,000 -592,000 8,706,000 -1,027,000 12,117,000 19,694,000 3,588,000 -1,569,000 4,938,000 11,000,000 8,842,000 1,194,000 12,357,000 216,000 7,054,000 602,000 4,172,000  
      investing activities
    		                                             
      capital expenditures
    		-10,623,000 -8,378,000 -10,976,000 -3,431,000 -3,574,000 -3,728,000 -3,918,000 -8,214,000 -9,941,000 -8,826,000 -8,351,000 -15,423,000 -11,366,000 -5,799,000 -8,010,000 -5,779,000 -5,267,000 -3,869,000 -3,469,000 -350,000 -12,399,000 -5,823,000 -5,997,000 -7,517,000 -9,967,000 -9,587,000 -2,396,000 -2,236,000 -1,719,000 -2,874,000 -2,699,000 -3,401,000 -3,278,000 -2,337,000 -2,217,000 -3,028,000 -2,020,000 -14,169,000 -5,508,000 -4,045,000 -2,069,000 -2,368,000 -2,272,000 -3,178,000 -1,128,000 
      free cash flows
    		8,317,000 18,550,000 -5,321,000 20,636,000 5,792,000 24,566,000 1,835,000 11,074,000 32,563,000 11,594,000 17,079,000 1,608,000 3,933,000 -6,801,000 -13,185,000 3,733,000 4,758,000 -3,044,000 9,767,000 7,735,000 11,974,000 6,416,000 -9,052,000 -969,000 4,867,000 -4,253,000 -1,895,000 13,653,000 -2,311,000 5,832,000 -3,726,000 8,716,000 16,416,000 1,251,000 -3,786,000 1,910,000 8,980,000 -5,327,000 -4,314,000 8,312,000 -1,853,000 4,686,000 -1,670,000 994,000  
      proceeds from the sale of property and equipment
    		227,000 6,000 91,000 -39,000 128,000 128,000 3,237,000 125,000 2,377,000 5,000 124,000 12,000 0 0 3,157,000 109,000 9,000 19,000 4,000 10,525,000    6,000 48,000   192,000 0 3,000 0 90,000 51,000 -16,000 17,000 9,000 0 0 61,000 12,000 391,000 -44,000 570,000 19,000 10,000 
      proceeds from sale of investments
    		0 0 1,679,000                                           
      purchases of investments
    		0 0 -451,000                                           
      acquisition of businesses, net of cash
    		-566,000       0 0 1,979,000 -14,068,000 -3,245,000 0 0 -12,990,000                               
      net cash from investing activities
    		-10,962,000 -12,552,000 -9,657,000 -4,631,000 -3,446,000 -3,600,000 -681,000 -8,089,000 -7,564,000 -6,842,000 -22,295,000 -18,656,000 -11,366,000 -5,799,000 -10,934,000 -5,670,000 -5,258,000 -3,850,000 -3,465,000 10,175,000 -12,399,000 -5,823,000 -5,997,000 -7,511,000 -9,839,000 -18,388,000 -13,065,000 -2,044,000 -1,719,000 -3,253,000 -7,007,000 -1,932,000 -2,338,000 2,019,000 351,000 -5,519,000 -2,020,000 -18,699,000 -2,231,000 -2,651,000 -2,902,000 -5,884,000 575,000 -3,142,000  
      financing activities
    		                                             
      (payments) proceeds of notes payable to banks
    		-1,589,000       -4,289,000 -2,549,000                                     
      proceeds from long-term debt
    		8,198,000 2,209,000 8,628,000 2,387,000 40,924,000 19,867,000 33,232,000 37,456,000 27,533,000 53,794,000 50,389,000 58,052,000 43,612,000 33,394,000 49,958,000 29,944,000 26,021,000 27,712,000 15,242,000 22,058,000 27,626,000 16,218,000 24,945,000 22,306,000 15,094,000 22,504,000 33,132,000 18,542,000                  
      payments of long-term debt
    		-3,900,000 -786,000 -777,000 -8,058,000 -45,856,000 -43,150,000 -33,069,000 -35,214,000 -50,682,000 -49,650,000 -50,633,000 -47,059,000 -43,930,000 -35,446,000 -29,494,000 -31,907,000 -28,601,000 -25,923,000 -27,106,000 -37,390,000 -35,976,000 -19,065,000 -17,652,000 -22,546,000 -15,997,000 -8,227,000 -17,354,000 -26,201,000 -26,865,000 -21,318,000 -11,112,000 -15,229,000 -17,281,000 -18,316,000 -13,155,000 -15,092,000 -13,788,000 -17,188,000 -11,674,000 -11,907,000 -12,425,000 -13,740,000 -13,868,000 -15,707,000  
      dividends paid
    		-985,000 -988,000 -1,164,000 -979,000 -983,000 -984,000 -1,130,000 -980,000 -983,000 -989,000 -1,154,000 -1,014,000 -1,024,000 -1,030,000 -1,031,000 -1,034,000 -980,000 -983,000 -1,131,000 -996,000 -1,015,000 -998,000 -1,175,000 -1,004,000 -1,006,000 -1,177,000 -1,043,000 -967,000 -1,056,000 -1,057,000 -1,008,000 -950,000 -1,057,000 -1,055,000 -1,037,000 -1,039,000 -1,029,000 -1,046,000 -1,056,000 -1,215,000 -845,000 -1,221,000 -1,110,000 -1,100,000 -1,157,000 
      proceeds from issuance of common shares
    		237,000 92,000 68,000 54,000 99,000 1,000 60,000 144,000 1,356,000 309,000 355,000 328,000 363,000 1,000 116,000 15,000 30,000 364,000 0 78,000 -92,000 30,000 236,000 184,000 29,000   -924,000 894,000   1,962,000 0   -130,000 268,000 110,000 0 0 20,000 20,000 40,000 -1,000  
      stock incentive plan payments
    		0 0 -3,799,000                                           
      purchase of common shares for treasury
    		-258,000 0 -131,000 -113,000 0   0 -612,000 0 -116,000 -92,000 0 0 -66,000 -1,000 0 -176,000 0 -4,000 -1,219,000 -3,011,000 -1,602,000 -403,000 -702,000 -1,456,000 -239,000 -36,000 -45,000 0 -110,000 0 236,000 -238,000 0 -193,000 -883,000 -1,405,000 -627,000 -3,625,000 -2,174,000 -130,000 -74,000 0  
      purchase of common shares for treasury from related parties
    		-4,255,000 -2,351,000 -881,000 -238,000 -2,233,000 -456,000 -5,452,000 -493,000 -7,947,000 -6,100,000 -3,624,000 -1,440,000 -2,140,000 0 -1,729,000 -1,000 -543,000 -870,000 -3,678,000 -1,248,000 0 0 -2,378,000 -1,922,000 -49,000 0 -2,055,000 -3,000 -2,266,000 -982,000 -723,000 -6,987,000 -1,486,000 105,000 -107,000 -474,000 -1,455,000 0 -33,000 -335,000 -1,075,000 0 -140,000 0  
      net cash from financing activities
    		-2,552,000 -4,768,000 -22,000 -7,001,000 -7,298,000 -21,838,000 -11,666,000 -3,376,000 -33,884,000 -2,355,000 -9,307,000 7,897,000 -883,000 431,000 15,098,000 -4,118,000 -380,000 1,752,000 -20,484,000 -16,679,000 -7,182,000 -5,015,000 5,711,000 -2,262,000 -4,687,000 13,529,000 11,134,000   -7,017,000 8,286,000 -3,891,000 -6,897,000 -9,232,000 469,000 -2,144,000 -4,025,000 7,899,000 2,659,000 -5,804,000 -4,156,000 -688,000 -2,009,000 -771,000  
      effects of exchange rate changes on cash, cash equivalents and restricted cash
    		612,000 2,465,000 1,615,000 -2,689,000 1,452,000 -1,291,000 -1,154,000 2,048,000 -480,000 146,000 724,000 18,000 -2,204,000 1,843,000 -765,000                939,000               
      net increase in cash, cash equivalents and restricted cash
    		6,038,000       9,871,000 576,000       -1,920,000    3,927,000    -2,222,000   -138,000 9,549,000   1,191,000               
      cash, cash equivalents and restricted cash at beginning of year
    		0 0 57,244,000 0 0 0 53,607,000 0 0 0 37,239,000 0 0 0 36,406,000 0 0 0 45,175,000 0 0 0 39,263,000 0 0 0 43,910,000 20,000 0 0 45,579,000               
      cash, cash equivalents and restricted cash at end of period
    		6,038,000 12,073,000 54,835,000  74,000 1,565,000 45,859,000  576,000    846,000 -4,527,000 34,630,000  4,872,000 -1,231,000 34,685,000  4,742,000 2,389,000 34,117,000  -100,000 -2,187,000 43,772,000  -7,356,000 -5,073,000 46,770,000               
      payments of notes payable to banks
    		  -1,966,000    -5,307,000                                       
      net decrease in cash, cash equivalents and restricted cash
    		  -2,409,000  74,000 1,565,000 -7,748,000    -5,448,000  846,000 -4,527,000 -1,776,000   -1,231,000 -10,490,000   2,389,000 -5,146,000                       
      benefit from accounts receivable allowances
    		               947,000 902,000 656,000 390,000 679,000 696,000 254,000 424,000 805,000 590,000 297,000 440,000 353,000 278,000 374,000 201,000 239,000 149,000 490,000 287,000 1,486,000 566,000 142,000 -10,000 548,000 93,000 274,000 46,000 438,000  
      benefit from inventory reserves
    		               2,480,000 -461,000 222,000 811,000 317,000 717,000 636,000 365,000 -5,000 393,000 808,000 87,000 674,000 273,000 586,000 869,000 -41,000 524,000 265,000 457,000 1,430,000 442,000 855,000 9,000 1,472,000 221,000 576,000 208,000 1,006,000  
      goodwill impairment
    		           0                                  
      gain from company owned life insurance policy
    		                                             
      loss on exit of business
    		           0 -171,000 207,000 989,000                               
      accounts receivable
    		               7,906,000 -6,036,000 -10,332,000 -3,114,000 7,081,000 -1,907,000 -10,521,000 -5,192,000 3,088,000 3,297,000 -16,553,000 391,000 12,972,000 -9,876,000 -4,960,000 -2,635,000 6,039,000 40,000 -9,140,000 -6,144,000 2,451,000 -4,859,000 2,484,000 -2,368,000 909,000 -6,522,000 -304,000 2,952,000 2,979,000  
      inventories
    		               -9,452,000 -5,232,000 -4,316,000 -5,154,000 107,000 4,753,000 -1,299,000 -3,481,000 -2,564,000 -2,777,000 -1,738,000 -2,376,000 -3,791,000 368,000 -5,462,000 -4,818,000 -2,797,000 50,000 2,056,000 -1,517,000 -3,503,000 -1,266,000 -3,242,000 1,657,000 616,000 -870,000 -1,930,000 -113,000 -2,843,000  
      prepaid expenses
    		               -6,955,000 -1,777,000 -2,376,000 8,134,000                           
      trade accounts payable and accrued liabilities
    		                6,544,000 8,245,000 795,000  4,845,000 6,822,000 -2,112,000  2,826,000 7,284,000 1,481,000  5,138,000 6,844,000 -3,112,000  6,812,000 2,245,000 -210,000  8,674,000 3,218,000 -2,331,000       
      accrued income and other taxes
    		               273,000                              
      proceeds from company owned insurance policy
    		                                             
      proceeds (payments) of notes payable to banks
    		   -54,000 751,000                                         
      cash, cash equivalents and restricted cash at end of year
    		          31,791,000                                   
      (gain) loss on sale of property and equipment
    		     -9,000 -1,843,000                     -9,000                  
      changes in operating assets and liabilities:
    		        22,627,000 -8,159,000 -1,758,000                                   
      proceeds from company owned life insurance policy
    		                                             
      payments on notes payable to banks
    		          -4,524,000                                   
      increase in notes payable to banks
    		           -878,000 2,236,000   -1,134,000 3,693,000 1,628,000 -3,811,000 823,000 3,494,000 1,811,000 3,337,000 1,123,000 -2,056,000 1,885,000 -1,307,000 5,315,000 1,076,000 1,119,000 936,000   697,000 -695,000 1,023,000 -509,000 -14,000 351,000 -629,000 -1,029,000 639,000 244,000 753,000 -3,000 
      adjustments to net cash from operations:
    		                                             
      gain from company-owned life insurance policy
    		            0 0 -4,364,000                               
      proceeds from company-owned life insurance policy
    		            0 0 6,909,000                               
      other – net
    		              630,000                               
      decrease in notes payable to banks
    		              -2,656,000                               
      other - net
    		               338,000 0 0 318,000 15,000 321,000 34,000 -364,000 327,000 -102,000 204,000 -137,000 40,000 98,000 -129,000 183,000 -131,000 68,000 83,000 193,000 126,000 -1,000 403,000 9,000 -304,000 275,000 91,000 5,000 -4,000  
      changes in operating assets and liabilities assets:
    		                                             
      trade accounts payables and accrued liabilities
    		                                       -1,754,000 4,707,000 6,818,000 -4,119,000 140,000  
      purchase of marketable securities
    		                   0 0 0 0 0 0 0 -496,000 0 0 -382,000 -4,308,000               
      proceeds from sale of marketable securities
    		                                             
      purchase of company owned life insurance policies
    		                                             
      effects of exchange rate changes on cash and cash equivalents
    		               -1,644,000 485,000 42,000 223,000 2,346,000 -50,000 988,000 -1,805,000 1,003,000 -408,000 -2,662,000 1,292,000 -22,000 1,001,000   -1,099,000 702,000 593,000 1,046,000 522,000 -158,000 -1,262,000 -652,000 -379,000 2,982,000 -282,000 1,719,000 662,000 228,000 
      income taxes - net
    		                 -33,000 -4,782,000  769,000 423,000 -328,000  1,669,000 986,000 -775,000  -3,031,000 572,000 1,733,000  610,000 717,000 1,997,000           
      loss on sale of property and equipment
    		                  -16,000                           
      income taxes
    		                                             
      proceeds from marketable securities
    		                    0    0    0                 
      purchase of company owned life insurance policy
    		                    0    0   0 0                 
      acquisition, net of cash acquired
    		                    0 0 0    -10,173,000                   
      fixed-term deposits
    		                           0 0 0 0               
      acquisition of businesses, net of cash acquired
    		                        80,000                     
      excess tax benefits from share-based awards
    		                                     -16,000 8,000 40,000 0 0 -20,000 63,000  
      net cash (used in) financing activities
    		                                             
      proceeds from the issuance of long-term debt
    		                             14,969,000 20,303,000 17,024,000 13,519,000 9,575,000 15,463,000 13,761,000 13,381,000 27,426,000 15,706,000 11,947,000 13,372,000 13,744,000 12,879,000 15,347,000  
      business acquisitions, net of cash acquired
    		                                       0 0 0 0 0  
      restricted cash and purchase of fixed-term deposits
    		                                   -2,500,000 0 -4,530,000 3,216,000 1,382,000 -1,224,000 -3,472,000 2,277,000   
      net increase in cash and cash equivalents
    		                               5,195,000   297,000 -2,203,000 4,797,000 -3,220,000 970,000 3,523,000 -3,860,000 200,000 887,000 921,000  
      cash and cash equivalents at beginning of year
    		                               0 0 0 30,737,000 0 0 0 30,393,000 0 0 0 29,643,000 0 0 
      cash and cash equivalents at end of year
    		                                             
      restricted cash and maturity (purchase) of fixed-term deposits - net
    		                                889,000 4,372,000 2,551,000           
      excess tax expenses from share-based awards
    		                                0 0 0           
      cash and cash equivalents at end of period
    		                                11,161,000 -3,032,000 31,034,000  4,797,000 -3,220,000 31,363,000  -3,860,000 200,000 30,530,000   
      net decrease in cash and cash equivalents
    		                                             
      excess tax benefits (expenses) from share-based awards
    		                                             
      income taxes payable
    		                                    1,360,000 -1,499,000 -196,000 -2,342,000 1,187,000 -877,000 -2,006,000 -1,290,000  
      earn-out consideration payments
    		                                           0  
      purchase of fixed term deposits
    		                                             
      fixed term deposits
    		                                             
      net investment in life insurance
    		                                             
      restricted cash and long-term term deposits
    		                                             
      earn-out consideration payment
    		                                             
      other—net
    		                                             
      restricted cash
    		                                             
      unrealized foreign currency gain on hedge contract
    		                                             
      other — net
    		                                            -42,000 
      less: income from discontinued operations
    		                                             
      income from continuing operations
    		                                             
      gain on acquisition of business
    		                                             
      proceeds from the sale of discontinued operations
    		                                             
      proceeds on life insurance
    		                                             
      payments on life insurance
    		                                             
      net cash from discontinued operations
    		                                             
      operating cash flows
    		                                             
      investing cash flows
    		                                             
      business acquisitions
    		                                            -10,000 
      cash and cash equivalents at beginning of period
    		                                             
      minority interest
    		                                             
      adjustments to reconcile net income to net cash from operating activities:
    		                                             
      stock-based compensation expense
    		                                             
      excess tax benefits from stock-based awards
    		                                             
      business acquisitions — net of cash acquired
    		                                             
      dividends paid — net
    		                                             
      financing cash flows
    		                                             
      changes in operating assets and liabilities, net of business acquisitions:
    		                                             
      stock based compensation expense
    		                                             
      business acquisitions, net of cash acquired of 187
    		                                             
      issuance of common shares
    		                                            0 
      decrease in cash and cash equivalents
    		                                             
      excess tax benefits from stock based awards
    		                                             
      increase in cash and cash equivalents
    		                                            869,000 
      changes in operating assets and liabilities, net of acquisitions:
    		                                             
      business acquisitions, net of cash received
    		                                             
      changes in operating assets and liabilities, net of acquisition:
    		                                             
      translation adjustment
    		                                             
      earnings of joint ventures
    		                                            59,000 
      dividends received from joint ventures
    		                                            788,000 
      gain on sale of joint venture
    		                                             
      proceeds from the sale of equity investment
    		                                             
      proceeds (payments) on life insurance — net
    		                                             
      earnings of joint venture
    		                                             
      dividends received from joint venture
    		                                             
      see notes to consolidated financial statements.
    		                                             
      asset impairment
    		                                             
      noncash abandonment/realignment charges
    		                                             
      cash surrender value of life insurance
    		                                             
      cumulative translation adjustment
    		                                             
      proceeds from the issuance of debt
    		                                            658,000 
      issuance (purchase) of common shares
    		                                             
      adjustments to reconcile net income to net cash from operations
    		                                             
      noncash abandonment charges
    		                                             
      payments of debt
    		                                            -1,947,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.